Previous close | 6.94 |
Open | 6.97 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 6.97 - 6.97 |
52-week range | 0.76 - 12.35 |
Volume | |
Avg. volume | 4,237 |
Market cap | N/A |
Beta (5Y monthly) | 0.90 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.88 |
Earnings date | 14 Aug 2023 - 18 Aug 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Active investing isn't easy, but for those that do it, the aim is to find the best companies to buy, and to profit...
In the latest trading session, Bellerophon Therapeutics (BLPH) closed at $7.65, marking a +1.06% move from the previous day.
Bellerophon (BLPH) is expected to provide updates on its proprietary INOpulse platform, being developed for treating several pulmonary hypertension indications, on its first-quarter earnings call.
Bellerophon Therapeutics (BLPH) closed at $10.04 in the latest trading session, marking a -0.4% move from the prior day.
Bellerophon Therapeutics (BLPH) closed the most recent trading day at $9.92, moving -0.6% from the previous trading session.
Bellerophon Therapeutics, Crawford, Riley Exploration Permian, Harrow Health and Lantheus have been highlighted in this Screen of The Week article.
We feel now is a pretty good time to analyse Bellerophon Therapeutics, Inc.'s ( NASDAQ:BLPH ) business as it appears...
Bellerophon Therapeutics (BLPH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Bellerophon Therapeutics (BLPH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Just because a business does not make any money, does not mean that the stock will go down. For example, although...